S
Sonya Abadali
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 2
Citations - 169
Sonya Abadali is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Gene & Genome-wide association study. The author has an hindex of 1, co-authored 1 publications receiving 95 citations.
Papers
More filters
Journal ArticleDOI
Synergistic effects of common schizophrenia risk variants.
Nadine Schrode,Seok-Man Ho,Kazuhiko Yamamuro,Amanda Dobbyn,Laura M. Huckins,Marliette R. Matos,Esther Cheng,P J Michael Deans,Erin Flaherty,Natalie Barretto,Aaron Topol,Khaled Alganem,Sonya Abadali,James Gardner Gregory,Emily Hoelzli,Hemali Phatnani,Vineeta Singh,Deeptha Girish,Bruce J. Aronow,Robert E. McCullumsmith,Gabriel E. Hoffman,Eli A. Stahl,Hirofumi Morishita,Pamela Sklar,Kristen J. Brennand +24 more
TL;DR: It is proposed that the links between rare and common variants implicated in psychiatric disease risk constitute a potentially generalizable phenomenon occurring more widely in complex genetic disorders.
Journal ArticleDOI
Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy
Lyudmyla Demyan,Amber N Habowski,Dennis Plenker,Daniel A King,Oliver J. Standring,Caitlin Tsang,Luce G. St. Surin,Arvind Rishi,James M. Crawford,Jeff Boyd,Shamsher Pasha,Hardik Patel,Zachary C. Galluzzo,Christine Metz,Peter K. Gregersen,Sharon S. Fox,M. Valente,Sonya Abadali,Steffi Matadial-Ragoo,Danielle K. DePeralta,Gary B. Deutsch,Joseph M. Herman,Mark A. Talamini,David A. Tuveson,Matthew J. Weiss +24 more
TL;DR: If patient-derived organoids (PDOs) may predict response to neoadjuvant chemotherapy in patients with pancreatic adenocarcinoma is evaluated to report a large single-institution organoid biobank, including ethnic minority samples.